8-K

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Form
Filing Date
Oct 2, 2017
Document Date
Sep 28, 2017
Form Description

Report of unscheduled material events or corporate event

Filing Group
Current Reports
Company
KemPharm
Issuer
KEMPHARM INC